Point72 Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,998
| Closed | -$38.8K | – | 2257 |
|
|
2023
Q2 | $38.8K | Sell |
1,998
-3,228
| -62% | -$62.7K | ﹤0.01% | 1132 |
|
|
2023
Q1 | $148K | Buy |
+5,226
| New | +$148K | ﹤0.01% | 1083 |
|
|
2019
Q3 | – | Sell |
-28,534
| Closed | -$1.59M | – | 1437 |
|
|
2019
Q2 | $1.59M | Buy |
+28,534
| New | +$1.59M | 0.01% | 609 |
|
|
2017
Q3 | – | Sell |
-45,750
| Closed | -$3.61M | – | 937 |
|
|
2017
Q2 | $3.61M | Buy |
+45,750
| New | +$3.61M | 0.02% | 472 |
|
|
2016
Q3 | – | Sell |
-11,344
| Closed | -$440K | – | 812 |
|
|
2016
Q2 | $440K | Sell |
11,344
-188,487
| -94% | -$7.31M | ﹤0.01% | 598 |
|
|
2016
Q1 | $8.09M | Buy |
+199,831
| New | +$8.09M | 0.06% | 302 |
|